Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates
08:11am, Wednesday, 24'th Jan 2024
Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago.
Elevance Health beats quarterly sales estimates
06:15am, Wednesday, 24'th Jan 2024
Elevance Health reported fourth-quarter sales that beat analysts' estimates on Wednesday, helped by higher premiums from its health insurance business and demand at its Carelon health services busines
Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics
02:01pm, Friday, 19'th Jan 2024
Get a deeper insight into the potential performance of Elevance Health (ELV) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimate
Can Higher Costs Affect Elevance Health's (ELV) Q4 Earnings?
10:51am, Friday, 19'th Jan 2024
Elevance Health's (ELV) fourth-quarter results are likely to reflect higher premiums and product revenues.
ELV or HQY: Which Is the Better Value Stock Right Now?
12:46pm, Wednesday, 17'th Jan 2024
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY). But which of these two companies is the best option for those looking f
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
11:18am, Wednesday, 17'th Jan 2024
Here is how Elevance Health (ELV) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.
Why You Should Retain Elevance (ELV) Stock in Your Portfolio
11:17am, Tuesday, 16'th Jan 2024
Elevance's (ELV) Carelon unit is expected to benefit from improving performance in the Behavioral Health business and post-acute care services.
Why Elevance Health (ELV) is a Top Momentum Stock for the Long-Term
11:18am, Monday, 15'th Jan 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Elevance Health (ELV) Stock Drops Despite Market Gains: Important Facts to Note
07:33pm, Friday, 12'th Jan 2024
In the closing of the recent trading day, Elevance Health (ELV) stood at $475.12, denoting a -1.49% change from the preceding trading day.
Here's Why Elevance Health (ELV) is a Strong Value Stock
11:19am, Friday, 12'th Jan 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Elevance Health (ELV) & Verizon Partner to Bring Health Equity
12:48pm, Thursday, 11'th Jan 2024
Elevance Health (ELV) launches a new program with an Affordable Connectivity Program offering free smartphones to eligible members.
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 24, 2024
04:05pm, Wednesday, 10'th Jan 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2023 financial results on January 24, 2024 at 6:00 a.m. Eastern Daylight Time (“EDT”). Manageme
Here are Wall Street's favorite stocks in the sector expected to grow profits the most in 2024
09:13am, Tuesday, 09'th Jan 2024
Each earnings reporting season, you can count on a flurry of articles with headlines saying companies “beat” consensus estimates for quarterly profits. But that “success” alone means nothing.
The 3 Best Dividend Stocks to Buy Now
12:56pm, Wednesday, 03'rd Jan 2024
If you're looking for the best dividend stocks to buy now, the WisdomTree U.S. Quality Dividend Growth Fund (NASDAQ: DGRW ) is an excellent place to start. DRGW is one of the largest U.S.-listed divi
ELV vs. GDRX: Which Stock Is the Better Value Option?
12:47pm, Friday, 22'nd Dec 2023
Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or GoodRx Holdings, Inc. (GDRX). But which of these two stocks offers value investors a
